NeoCore Technology Co., Ltd. (TPEX:4131)

Taiwan · Delayed Price · Currency is TWD

32.50

+0.15 (0.46%)

Aug 26, 2026, 1:08 PM CST

-3.13% (1Y)

Market Cap	1.29B -5.4%
Revenue (ttm)	277.54M +83.3%
Net Income	-33.12M
EPS	-0.83
Shares Out	39.86M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	51,730
Open	31.50
Previous Close	32.35
Day's Range	29.30 - 32.50
52-Week Range	29.40 - 42.45
Beta	-0.27
Analysts	n/a
Price Target	n/a
Earnings Date	Aug 26, 2026

About NeoCore Technology

NeoCore Technology Co., Ltd. designs, manufactures, and sells biochips and rapid nucleic acid hybridization devices. The company’s products include food safety testing kits, including DR. Meat Kit, DR. Food-Ent kit, rapid test kit, and ELISA kit; infectious disease testing, such as DR. HPV Genotyping IVD Kit, DR. MTBC Screen IVD Kit, and DR. Microorganism IVD Kit (Non-sterile); and biochip instruments and equipment, including DR. AiM Reader, DR.Mini Oven, and DR.Fluidic Station. In addition, the company engages in the wholesale and retail of co... [Read more]

Industry Biotechnology

Sector Healthcare

Founded 1987

Employees 44

Stock Exchange Taipei Exchange

Ticker Symbol 4131

Full Company Profile

Financial Performance

In 2025, NeoCore Technology's revenue was 244.66 million, an increase of 297.52% compared to the previous year's 61.55 million. Losses were -30.87 million, -35.87% less than in 2024.

Financial Statements